Journey Medical Corp
NASDAQ:DERM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Journey Medical Corp
NASDAQ:DERM
|
US |
|
W
|
Wahana Ottomitra Multiartha Tbk PT
XMUN:WB7
|
ID |
|
MAP Aktif Adiperkasa Tbk PT
IDX:MAPA
|
ID |
|
C
|
Creverse Inc
KOSDAQ:096240
|
KR |
|
B
|
Bumi Resources Tbk PT
XMUN:PJM
|
ID |
|
B
|
BKW AG
SWB:B9W
|
CH |
|
Bridgestone Corp
F:BGT
|
JP |
Wall St Price Targets
DERM Price Targets Summary
Journey Medical Corp
According to Wall Street analysts, the average 1-year price target for
DERM is 14.79 USD with a low forecast of 14.14 USD and a high forecast of 15.75 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DERM's stock price target?
Price Target
14.79
USD
According to Wall Street analysts, the average 1-year price target for
DERM is 14.79 USD with a low forecast of 14.14 USD and a high forecast of 15.75 USD.
What is the Revenue forecast for Journey Medical Corp?
Projected CAGR
48%
Over the last 5 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 48%.
What is the Gross Profit forecast for Journey Medical Corp?
Projected CAGR
47%
Over the last 5 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 47%.